Kiromic BioPharma Inc
KRBP - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.31M
Close$
$-0.61
851.9% downside
Current Fair Value
851.9% downsideOvervalued by 851.9% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $2.31 Million |
|---|---|
| Enterprise Value | $15.74 Million |
| Earnings per Share | $-1.03 |
| Beta | 1.66 |
| Outstanding Shares | 28,518,500 |
Return
| Return on Equity | 214.39% |
|---|---|
| Return on Assets | -315.80% |
| Return on Invested Capital | 197.03% |
Valuation & Multiples
| P/E Ratio | -0.08 |
|---|---|
| PEG | -0.2 |
| Price to Sales | - |
| Price to Book Ratio | -0.08 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -0.65 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.93 |
| Debt to Equity | -1.16 |
Revenue Sources
No data
Last Earnings Call
Report Date
November 6, 2025
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Kiromic BioPharma Inc
19 employees
Kiromic BioPharma, Inc. is an immuno-oncology biopharmaceutical company focused on discovering, developing, and commercializing novel immuno-oncology applications through its robust product pipeline. The pipeline development is leveraged...